Company / PP&E per Share
ELITE PHARMACEUTICALS INC /NV/ PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.01
FY2025
5-year range
$0.01 / $0.01
FY2021-FY2025
Trend
-3.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2022 to $0.01 in FY2016.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of +2.0%.
Declined from $0.01 to $0.01 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +2.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 3.7% year-over-year.
- Peak pp&e per share was recorded in FY2016.
- Lowest pp&e per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -3.7% |
| FY2024 | $0.01 | -2.7% |
| FY2023 | $0.01 | +74.8% |
| FY2022 | $0.01 | -25.4% |
| FY2021 | $0.01 | -9.7% |
| FY2020 | $0.01 | -16.7% |
| FY2019 | $0.01 | +8.6% |
| FY2018 | $0.01 | -23.7% |
| FY2017 | $0.01 | -1.1% |
| FY2016 | $0.01 | +12.5% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026